Reversal of the Antithrombotic Action of New Oral Anticoagulants

NCT01478282 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Thrombosis
Anticoagulant-induced Bleeding
Anticoagulant Overdosage
Hemorrhage

Interventions

DRUG: Rivaroxaban
DRUG: Dabigatran

Sponsor

Gines Escolar

Collaborators

[object Object]